LabGenius Therapeutics Revenue

Biotechnology Research • London, England, United Kingdom • 51-100 Employees

LabGenius Therapeutics revenue & valuation

Annual revenue	$190,200
Revenue per employee	$3,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$608,640
Total funding	$44,500,000

Key Contact at LabGenius Therapeutics

James Field

Ceo & Founder

Company overview

Headquarters	100 Drummond Road, Bermondsey, London, UK SE16 4DG, GB
Websites	labgeniustx.com labgeni.us
NAICS	541714
Keywords	Medical, Health, Dna Libraries
Founded	2012
Employees	51-100
Socials

LabGenius Therapeutics Email Formats

LabGenius Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	48.2%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	24.1%
{first name}@company.com	john@company.com	12.4%
{last name}.{first name}@company.com	doe.john@company.com	8.9%
{first name}{last name}@company.com	johndoe@company.com	6.4%

About LabGenius Therapeutics

LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVA™ is both modality and format-agnostic, LabGenius' internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Senior

Manager

Employees by Department

LabGenius Therapeutics has 25 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore LabGenius Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-21	5	$44,500,000

Funding Insights

$44,500,000

Total funding amount

$44,500,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

LabGenius Therapeutics is located in London, England, GB.

LabGenius Therapeutics generates an estimated annual revenue of $190,200. This revenue figure reflects the company's market position and business performance in its industry.

LabGenius Therapeutics has an estimated valuation of $608,640. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

LabGenius Therapeutics was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

LabGenius Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

LabGenius Therapeutics has raised a total of $44,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at LabGenius Therapeutics

James Field

Ceo & Founder

4.8

40,000 users